Nutr Res Pract.  2019 Feb;13(1):58-63. 10.4162/nrp.2019.13.1.58.

Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model

Affiliations
  • 1CHA University School of Medicine, 120, Haeryong-ro, Pocheon-si, Gyeonggi 13488, Korea. sang.choi@cha.ac.kr
  • 2Division of Nutrition and Metabolism, Korea Food Research Institute, Jeonju, Jeonbuk 55365, Korea.
  • 3Department of Nutritional Science and Food Management, Ewha Womans University, Seoul, 03760, Korea.
  • 4Chaum Life Center CHA University, 442, Dosan-daero, Gangnam-gu, Seoul, 06062, Korea.

Abstract

BACKGROUND/OBJECTIVES
Telomeres are located at the chromosomal ends and progressively shortened during each cell cycle. Telomerase, which is regulated by hTERT and c-MYC, maintains telomeric DNA sequences. Especially, telomerase is active in cancer and stem cells to maintain telomere length for replicative immortality. Recently we reported that walnut phenolic extract (WPE) can reduce cell viability in a colon cancer stem cell (CSC) model. We, therefore, investigated the effect of WPE on telomere maintenance in the same model.
MATERIALS/METHODS
CD133+CD44+ cells from HCT116, a human colon cancer cell line, were sorted by Fluorescence-activated cell sorting (FACS) and treated with WPE at the concentrations of 0, 10, 20, and 40 µg/mL for 6 days. Telomere lengths were assessed by quantitative real-time PCR (qRT-PCR) using telomere specific primers and DNA extracted from the cells, which was further adjusted with single-copy gene and reference DNA (ddCt ). Telomerase activity was also measured by qRT-PCR after incubating the PCR mixture with cell protein extracts, which was adjusted with reference DNA (dCt ). Transcriptions of hTERT and c-MYC were determined using conventional RT-PCR.
RESULTS
Telomere length of WPE-treated cells was significantly decreased in a dose-dependent manner (5.16 ± 0.13 at 0 µg/mL, 4.79 ± 0.12 at 10 µg/mL, 3.24 ± 0.08 at 20 µg/mL and 3.99 ± 0.09 at 40 µg/mL; P = 0.0276). Telomerase activities concurrently decreased with telomere length (1.47 ± 0.04, 1.09 ± 0.01, 0.76 ± 0.08, and 0.88 ± 0.06; P = 0.0067). There was a positive correlation between telomere length and telomerase activity (r = 0.9090; P < 0.0001). Transcriptions of both hTERT and c-MYC were also significantly decreased in the same manner.
CONCLUSIONS
In the present cell culture model, WPE reduced telomere maintenance, which may provide a mechanistic link to the effect of walnuts on the viability of colon CSCs.

Keyword

Walnut; colonic neoplasms; stem cells; telomere; telomerase

MeSH Terms

Base Sequence
Cell Culture Techniques
Cell Cycle
Cell Line
Cell Survival
Colon*
Colonic Neoplasms*
DNA
Flow Cytometry
Humans
Juglans*
Phenol*
Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
Stem Cells*
Telomerase*
Telomere*
DNA
Phenol
Telomerase

Figure

  • Fig. 1 WPE reduced both telomere length and telomerase activity. (a) Relative telomere length (ddCt) of HCT116 CD133+CD44+ cells with respect to the WPE concentration. One-way ANOVA was used to determine the association between telomere length and WPE. Values are represented as Mean±SE, P < 0.05. Significant differences are observed for values having bars with different letters. (b) Relative telomerase activity (dCt) of HCT116 CD133+CD44+ cells with respect to the WPE concentration. One-way ANOVA was used to determine the association between telomerase activity and WPE. Values are represented as Mean±SE, P < 0.05. Significant differences are observed for values having bars with different letters. (c) Correlation between telomere length and telomerase activity. Correlation was assessed using Spearman's correlation. The correlation coefficient is observed to be r = 0.9090 and P < 0.0001.

  • Fig. 2 WPE reduced the transcriptions of hTERT and c-MYC. To determine the transcription of hTERT and c-MYC genes RT-PCR was conducted with RPLP0 gene as an endogenous control. WPE downregulated the transcriptions of hTERT (a) and c-MYC (b) in a dose dependent manner. Values are represented as Mean±SE, P < 0.05 by one-way ANOVA. Significant differences are observed for values having bars with different letters.


Reference

1. Sabaté J, Ang Y. Nuts and health outcomes: new epidemiologic evidence. Am J Clin Nutr. 2009; 89:1643S–1648S.
Article
2. Yu Z, Malik VS, Keum N, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS, Bao Y. Associations between nut consumption and inflammatory biomarkers. Am J Clin Nutr. 2016; 104:722–728.
Article
3. Calcabrini C, De Bellis R, Mancini U, Cucchiarini L, Stocchi V, Potenza L. Protective effect of Juglans regia L. walnut extract against oxidative DNA damage. Plant Foods Hum Nutr. 2017; 72:192–197.
Article
4. Feldman EB. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr. 2002; 132:1062S–1101S.
Article
5. Tsoukas MA, Ko BJ, Witte TR, Dincer F, Hardman WE, Mantzoros CS. Dietary walnut suppression of colorectal cancer in mice: mediation by miRNA patterns and fatty acid incorporation. J Nutr Biochem. 2015; 26:776–783.
Article
6. Lee J, Kim YS, Lee J, Heo SC, Lee KL, Choi SW, Kim Y. Walnut phenolic extract and its bioactive compounds suppress colon cancer cell growth by regulating colon cancer stemness. Nutrients. 2016; 8:E439.
Article
7. Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, Del Bianco P, Nitti D, De Rossi A. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer. 2010; 102:1300–1305.
Article
8. Zhang C, Chen X, Li L, Zhou Y, Wang C, Hou S. The association between telomere length and cancer prognosis: evidence from a meta-analysis. PLoS One. 2015; 10:e0133174.
Article
9. Zhao Y, Cheng D, Wang S, Zhu J. Dual roles of c-Myc in the regulation of hTERT gene. Nucleic Acids Res. 2014; 42:10385–10398.
Article
10. Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer. Tumour Biol. 2015; 36:5999–6010.
Article
11. Leão R, Apolónio JD, Lee D, Figueiredo A, Tabori U, Castelo-Branco P. Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer. J Biomed Sci. 2018; 25:22.
Article
12. Miller DM, Thomas SD, Islam A, Muench D, Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res. 2012; 18:5546–5553.
Article
13. Choi J, Shin PK, Kim Y, Hong CP, Choi SW. Metabolic influence of walnut phenolic extract on mitochondria in a colon cancer stem cell model. Eur J Nutr. Forthcoming 2018.
Article
14. Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr. 2001; 131:2837–2842.
15. Min SJ, Lim JY, Kim HR, Kim SJ, Kim Y. Sasa quelpaertensis leaf extract inhibits colon cancer by regulating cancer cell stemness in vitro and in vivo. Int J Mol Sci. 2015; 16:9976–9997.
Article
16. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30:e47.
Article
17. Hou M, Xu D, Björkholm M, Gruber A. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem. 2001; 47:519–524.
Article
18. Sadr M, Noori Mugahi SM, Hassanzadeh G, Nadji SA, Kiani A, Abedini A, Javadi A, Mohammadi F, Masjedi MR, Bahadori M. Telomere shortening in blood leukocytes of patients with chronic obstructive pulmonary disease. Tanaffos. 2015; 14:10–16.
19. Herbert BS, Hochreiter AE, Wright WE, Shay JW. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc. 2006; 1:1583–1590.
Article
20. Liu T, Liang X, Li B, Björkholm M, Jia J, Xu D. Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects. Br J Cancer. 2013; 108:2272–2280.
Article
21. Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR, Patmasiriwat P. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int J Mol Sci. 2010; 11:5323–5338.
Article
22. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000; 132:365–386.
Article
23. Gilley D, Tanaka H, Herbert BS. Telomere dysfunction in aging and cancer. Int J Biochem Cell Biol. 2005; 37:1000–1013.
Article
24. Aviv A, Anderson JJ, Shay JW. Mutations, cancer and the telomere length paradox. Trends Cancer. 2017; 3:253–258.
Article
25. Astuti Y, Wardhana A, Watkins J, Wulaningsih W, Network PR. PILAR Research Network. Cigarette smoking and telomere length: a systematic review of 84 studies and meta-analysis. Environ Res. 2017; 158:480–489.
Article
26. Ennour-Idrissi K, Maunsell E, Diorio C. Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomarkers Prev. 2017; 26:3–10.
Article
27. Fang X, Hu T, Yin H, Yang J, Tang W, Hu S, Xu X. Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer. Int J Oncol. 2017; 51:525–532.
Article
28. Martin SL, Kala R, Tollefsbol TO. Mechanisms for the inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase (hTERT) down-regulation. Curr Cancer Drug Targets. 2018; 18:97–106.
Article
29. Zhdanov DD, Pokrovsky VS, Pokrovskaya MV, Alexandrova SS, Eldarov MA, Grishin DV, Basharov MM, Gladilina YA, Podobed OV, Sokolov NN. Inhibition of telomerase activity and induction of apoptosis by rhodospirillum rubrum L-asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes. Cancer Med. 2017; 6:2697–2712.
Article
30. Lu Y, Leong W, Guérin O, Gilson E, Ye J. Telomeric impact of conventional chemotherapy. Front Med. 2013; 7:411–417.
Article
31. Marfil V, Blazquez M, Serrano F, Castell JV, Bort R. Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex. Oncogene. 2015; 34:3011–3022.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr